HoyleCohen’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
CCM
HoyleCohen's NVS Position: Q2 2024 in Review
HoyleCohen sold out of Novartis (NVS) in Q2 2024, closing a stake of 4,147 shares — an estimated $401K sold.
HoyleCohen first reported a position in NVS in Q4 2017 and held it in 25 quarters. The position peaked at $487K in Q4 2021. 1,306 funds tracked by Wall St. Rank hold NVS as of Q2 2024.
- HoyleCohen reported no remaining Novartis position as of Q2 2024 after selling out during the quarter.
- HoyleCohen sold 4,147 Novartis shares in Q2 2024, an estimated $401K.
- HoyleCohen first reported a position in Novartis in Q4 2017 and held it in 25 quarters.
- HoyleCohen's Novartis position peaked at $487K in Q4 2021.
- 1,306 funds tracked by Wall St. Rank held Novartis as of Q2 2024.
Based on HoyleCohen's 13F filing for Q2 2024, filed 19 Jul 2024.